$7.08
-0.06[-0.84%]
At close: Apr 29
$7.08
0[0.00%]
After Hours: 4:00PM EDT
Fulcrum Therapeutics: Insider buying and selling updated today.
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
---|---|---|---|---|---|---|---|---|---|---|
Mar 08, 2024 | Greg Tourangeau | VICE PRESIDENT, FINANCE | -4.884K | $11.72 | -$57.22K | SELL | -29.26% | 11.807K | Mar 08 | View |
Mar 05, 2024 | Alex Sapir | SEE REMARKS | 43.36K | $11.35 | $492.03K | BUY | ∞ | 43.36K | Mar 04 | View |
May 11, 2023 | Greg Tourangeau | PRINCIPAL ACCOUNTING OFFICER | -210 | $3.31 | -$695.10 | SELL | -1.30% | 15.992K | May 10 | View |
Jan 24, 2023 | RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPPeter KolchinskyRajeev Shah | 10% OWNER | 1.923076M | $13.00 | $25.00M | BUY | 19.85% | 11.609704M | Jan 20 | View |
Jan 13, 2023 | Robert J Gould | INTERIM PRESIDENT & CEO | -6.766K | $15.00 | -$101.49K | SELL | -1.34% | 499.864K | Jan 13 | View |
Jan 06, 2023 | RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPPeter KolchinskyRajeev Shah | 10% OWNER | 180.703K | $7.28 | $1.31M | BUY | 1.90% | 9.686628M | Jan 04 | View |
Dec 29, 2022 | RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPPeter KolchinskyRajeev Shah | 10% OWNER | 4.089K | $5.99 | $24.51K | BUY | 0.04% | 9.505925M | Dec 27 | View |
Dec 21, 2022 | RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPPeter KolchinskyRajeev Shah | 10% OWNER | 98.787K | $5.90 | $582.81K | BUY | 1.05% | 9.501836M | Dec 19 | View |
Dec 16, 2022 | RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPPeter KolchinskyRajeev Shah | 10% OWNER | 2.403049M | $5.44 | $13.07M | BUY | 34.33% | 9.403049M | Dec 14 - Dec 16 | View |
Jun 08, 2022 | Robert J Gould | DIRECTOR | 0 | $7.96 | -$17.84K | SELL-OPTIONS | 0.00% | 506.63K | Jun 07 | View |
Jun 06, 2022 | Robert J Gould | DIRECTOR | 0 | $7.92 | -$10.49K | SELL-OPTIONS | 0.00% | 506.63K | Jun 02 - Jun 06 | View |
Apr 11, 2022 | Robert J Gould | DIRECTOR | 0 | $15.93 | -$91.08K | SELL-OPTIONS | 0.00% | 506.63K | Apr 07 | View |
Apr 05, 2022 | Robert J Gould | DIRECTOR | 0 | $16.00 | -$1.54M | SELL-OPTIONS | 0.00% | 506.63K | Apr 01 - Apr 05 | View |
Aug 12, 2021 | Christopher Moxham | CHIEF SCIENTIFIC OFFICER | 0 | $12.72 | -$505.42K | SELL-OPTIONS | 0.00% | 0 | Aug 10 | View |
Aug 12, 2021 | Bryan Stuart | SEE REMARKS | 0 | $14.13 | -$754.60K | SELL-OPTIONS | 0.00% | 0 | Aug 10 - Aug 11 | View |
Jun 29, 2021 | Christopher Morabito | CHIEF MEDICAL OFFICER | 1.1K | $9.16 | $10.08K | BUY | ∞ | 1.1K | Jun 28 | View |
Jun 29, 2021 | Curt Oltmans | SVP, GENERAL COUNSEL | 1.088K | $9.01 | $9.80K | BUY | ∞ | 1.088K | Jun 28 | View |
Jun 29, 2021 | Peter Thomson | VP FINANCE & ACCOUNTING | 2.3K | $9.00 | $20.70K | BUY | ∞ | 2.3K | Jun 28 | View |
Jun 29, 2021 | James A Geraghty | DIRECTOR | 10K | $9.16 | $91.60K | BUY | 12.39% | 90.714K | Jun 28 | View |
Browse insider trades on all stocks.